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ABSTRACT 
Vitiligo is one of the skin diseases causing cosmetic problem. It is a common puzzling disorder of great 
socio-medical importance characterized by hypo pigmented and/or depigmented milky white or ivory 
white maculae on the skin, resulting from the loss of cutaneous melanocytes. It affects approximately 1-
4% of world population in both sexes equally. It inflates an inferiority complex in the person affected. 
The exact cause of Vitiligo remains obscure, auto immunity may play a role in the development of the 
disease. It is a challenging problem to all systems of medicine. Modern science treats it with topical & 
systemic photo chemotherapy, corticosteroids & skin grafting which is costly and not much effective 
added with more side effects. Based on the clinical features of Switra, it can be correlated to ‘Vitiligo’ of 
the Modern medicine In order to evaluate an ideal management for the relief and cure of Switra, an 
attempt has been made in this work to establish the therapeutic potentialities of ‘Dhatryadi Kwatha & 
Aparajitha Lepa’ in Switra. The Yoga, Dhatryadi Kwatha derives its reference from a renowned classic- 
‘chakradhatta’ and ‘Aparajitha lepa’ from ‘Rajamarthanda’. 30 children with Switra were taken up for 
the study of age between 0-16years and were given treatment for 3 months consisting of external 
application with Aparajitha lepa and internal medication with Dhatryadi Kwatha. The study has been 
subjected to statistical analysis, in which the results were found to be significant.  
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INTRODUCTION
The description of Switra is available since Vedic 
literature. The terms used in the place of Switra in Vedic 
literature are Shwetakushta, Kilasa and Palita. The term 
“Kilasa”-its meaning in Rig-Veda explained as the “Spotted 
deer”. Hence this term devotes the impairment of the color 
of the skin. The term Switra derives from the root. 
“Swetate twaganena switram” That means which gives 
white color to the skin [1]. Almost all the ancient scholars 
give the justification of description of Switra starting with 
Nidana and ending with Chikitsa as that of Kushtha. Later 
authors differentiated Switra from Kushtha, by its being 
less destructive to the tissues of the body. All these facts 
put together, the term Switra is used separately from 
Kushtha, in which everything else like the destruction of 
tissues, does not occur. 
 If Switra is characterized by a change in the color 
of the skin, it can be equated to that of “Vitiligo” in modern 
medicine. The term Vitiligo was fist mentioned by “Celcus”, 
a scientist and Physician of Rome in second century. This 
term has been derived from a Latin word, "Vitilious" [2]  
meaning a “Calf” comparing the whiteness of the skin of 
the calf to that of human skin. It affects approximately 1-
4% of world population in both sexes equally. However, its 
incidence ranges from 0.1 to > 8.8 % across the country 
and in different countries of the globe[3],[4].  
The genetic epidemiology of Vitiligo is part of a 
broader genetically determined autoimmune and auto 
inflammatory diathesis. Many authorities believe that the 
cause of melanocytes destruction in Vitiligo is an 
endogenous cellular abnormality. It has been suggested 
that melanocytes are destroyed because of the 
accumulation of a toxic melanin synthesis intermediate 
and / or lack of protection from hydrogen peroxide and 
other oxygen radicals. About 50% of children with Vitiligo 
have onset before 18 years of age, and 25% demonstrate 
depigmentation before age 8. [5] Most children have 
generalized form, but the segmental type is more common 
among children than among adults. Patient with 
generalized form usually present with a symmetrical 
pattern of white macules and patches. In segmental type, 
depigmented areas are limited to a quasi-dermatomal 
distribution. 
 Light microscopic examination of early lesions 
shows mild inflammatory change, over a time degenerative 
changes occur in melanocytes, leading to their complete 
disappearance. The two most common differential 
diagnoses are tinea versicolor and post inflammatory hypo 
pigmentation and leprosy[5,6]. Then coming to the 
treatment, localized areas of Vitiligo may respond potent 
topical steroid, topical tacrolimus or topical. In patient 
with more extensive involvement, narrow banded 
ultraviolet blue B is the treatment of choice, but response 
to therapy slowly, taking months to years and spontaneous 
remission may be seen. All areas of Vitiligo are 
susceptibility to sun damage, are care should be taken to 
minimize sun exposure of affected areas.  
In Ayurveda, Shvitra or Kilasa is the term 
employed to describe hypo pigmentation disorders of the 
skin. Shvitra is caused by various dietic and behavioural 
factors which aggravate the Tridoshas, especially 
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the Kapha dosha vitiating the Raktha, Mamsa and Meda 
Dhatu.[7] 
 Many Ayurvedic drugs are well known for the 
regeneration of melanocytes, among which ‘Dhatryadi 
Kwatha & Aparajitha Lepa’ is one. The present study was 
planned to study its efficacy in the regeneration of 
melanocytes. The outcome of treatment in 30 cases 
of Shvitra vis-à-vis Vitiligo receiving Dhatryadi kwatha [8]. 
as internal and Aparajitha lepa [9]. as a external application 
were analyzed and compared before and after treatment. 
Materials and Methods 
A) MATERIALS 
a) Amalaki phala- 1part 
b) Khadira Twak - 1part 
c) Bakuchi bija - 1part 
d) Swetha Aparajitha mula 
B) METHODS 
(a) Preparation of Study Drug 
1. Dhatryadi kwatha 
2. Aparajitha lepa 
Preparation of internal medication 
 Amalaki, Khadira, Bakuchi were taken in equal 
quantity and subjected into coarse powder. Now the drug 
is made into Kwatha as per classics by adding water in the 
ratio 1:8 and reduced to ¼ quantity. It is administered 
according to the Vaya, Bala and Agni of the patient. 
Preparation of external application 
 Root of Swetha Aparajitha was made into paste by 
rubbing it on a stone through the aid of water, and then 
applied over the affected areas and made to expose to the 
morning sunlight until it gets dry. 
Conduct of trial 
 Clinical evaluation 
 Laboratory evaluation 
1. Clinical evaluation: The trial was conducted in four 
phases. 
Phase I 
Study Design - Open label, Randomized 
Type of Trial - Efficacy Trial 
No. of Objects - 30 
Duration of Treatment - 90 Days 
Selection Of Patients - Total 30 patients were selected 
and registered from O.P.D. of Kaumarabhritya 
department, S.V.Ayurvedic hospital, Tirupati. based on 
the criteria mentioned below. 
Inclusive Criteria 
1. Children of age group 0-16years. 
2. Patients with Sadhya Lakshana of Shvitra (Peeta 
chavi, Pandu varna, Ruksha, less than 1yr old) 
3. Size of patch up to 5cm × 5cm 
4. Patients having Shvitra patch with normal sensation 
in touch 
Exclusive Criteria 
1. Age group > 16 years. 
2. Lesion over the lips, genital & burnt areas 
3. More than one year old 
4. The old refractory causes not responding after 
extensive use of modern medicine. 
5. Vitiligo associated with malignant melanoma, 
albinism and other skin-disease 
6. Patient suffering from other systemic disease& 
autoimmune disorder. 
Phase-II 
 Patients were clinically assessed basing on 
parameters before treatment. 
 Rogi Pariksha and Bala of patient were assessed prior 
to treatment. 
Phase-III 
 Patients were given the Kashaya as per Vaya, Bala, 
Agni. 
 Kashaya was given 3 times per day after food. 
 Lepa was applied over the affected part through the 
aid of water 
 Observed for burning sensation or increase in pain or 
roughness. 
 The observations were recorded on the basis of 
gradation before and after treatment. 
 The dropped out cases were not included in 
statistical analysis. 
Phase-IV 
 Patients were assessed according to following 
parameters for 3 months with follow up for every 15 days. 
Table 1: Subjective parameters 
Symptoms Grading 
Twak Shwetata Grade 0 Normal Normal skin colour 
Grade 1 Mild Less depigmentation at margins and more pigmentation over a lesion. 
Grade 2 Moderate Depigmentation is more than pigmentation or equal over a lesion. 
Grade 3 Severe No pigmentation, totally white colour 
Twak rukshata Grade 0 Normal No dryness 
Grade 1 Mild Dryness on exposure to sunlight and other allergens. 
Grade 2 Moderate Dryness during exposure to cold environment 
Grade 3 Severe Always dryness 
Kandu Grade0 Normal No itching 
Grade1 Mild Itching on exposure to cold, sunlight and other allergens. 
Grade2 moderate Itching on exposure to cold environment 
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Grade3 Severe Severe itching 
 
 
Daha 
Grade 0 Normal No burning sensation 
Grade 1 Mild Burning sensation on exposure to midnoon sunlight. 
Grade 2 Moderate Burning sensation on exposure to morning sunlight and other irritants. 
Grade 3 Severe Always burning sensation 
 
Roma 
vivarnata 
Grade 0 Normal Normal hair colour 
Grade 1 Mild less than 20% of hair over the lesion has Vivarnata. 
Grade 2 Moderate 25-75% of hair over the lesion has Vivarnata 
Grade 3 Severe more than 75% of hair over the lesion has Vivarnata 
International protocol for grading of repigmentation10 
Grade 1 : Diffuse lightening usually seen at margins (tan colour) 
Grade 2 : perifolicular repigmentation 
Grade 3 : spreading of perifolicular repigmentation 
Grade 4 : coalescing pigmentation with areas of repigmentation in between 
Grade 5 : confluent repigmentation with remnant islets of depigmentations inbetween 
Grade 6 : complete repigmentation 
Statistical Evaluation of Results 
The observations obtained from the clinical study, their interpretations and results are classified as, 
Table 2: Age wise distribution of 30 patients 
Age( in years) No. of patients Percentage 
0-4 01 3.33 
5-8 10 33.33 
9-12 11 36.33 
13-16 08 26.66 
Table 3: Gender wise distribution of 30 patients 
Gender No. of patients Percentage 
Male 21 70 
Female 09 30 
Table 4: Distribution of patients according to chief complaints: 
Chief complaints No of patients Percentage 
Twakshwethata 30 100 
Twakrukshata 9 30 
Daha 2 6.66 
Kandu 4 13.33 
Vrana 2 6.66 
Romavivarnata 7 23.33 
Table 5: Distribution of patients according to new patches during treatment 
New Patch No. of patients Percentage 
Appeared 10 33.33 
Not appeared 20 66.66 
Effect of Therapies on Patients 
Table 6: The effect of the therapy on various parameters 
S.No Characteristics No. of 
Observations 
Mean Score SD SE t p Remarks 
BT AT 
1 Twak shwetata 30 2.73 1.57 1.04 0.19 6.4839 <0.001 Extremely 
Significant 
2 Twak rukshata 9 0.67 0.30 0.70 0.13 2.7959 <0.001 Highly 
Significant 
3 Kandu 4 0.27 0.07 0.25 0.05 2.1623 >0.05 Not Significant 
4 Daha 2 0.07 0.00 0.0 0.0 1.2392 <0.1608 Not Significant 
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5 Romavivarnata 7 0.63 0.19 0.60 0.11 2.4433 <0.02 Significant 
Table 7: The effect of the therapy on repigmentation 
S. No Characteristics No. of 
Observations 
Mean Score SD SE t  
p 
 
Remarks BT AT 
1 Repigmentation 30 0.00 1.90 1.83 0.33 5.6990 <0.0001 Extremely 
Significant 
Table 8: Percentage of overall improvement in each ailment after treatment in 30 patients with respect to 
assessment criteria 
Ailment Percentage improvement 
Twakswetata 42.49% 
Twakrukshata 55.22% 
Kandu 74.07% 
Daha 100% 
Romavivarnata 69.84% 
 
 
Discussion on mode of action of internal medication 
 The decoction of Amalaki contains the compounds 
which have the dyeing action. It contains tannins- gallic 
acid & ellagic acid. Amalaki being, Alavana pancha rasa, 
Sita virya and Madhura vipaka acts as Tridoshahara. Due to 
Rasayana and Vayasthapana property leads to formation 
of Prasastha dhatu which slows down the degeneration of 
cells and regenerates new cells as well. Even it has 
Kushthagna property. Switra being an auto-immune 
disorder. The potent immune modulator Amalaki present 
in Dhatryadi yoga acts against the Auto-Immune 
Mechanism in which antibodies against melanin were 
proved to be isolated from the serum of Vitiligo patients.. 
Khadira is having Tikta, Kashaya rasa, Sita virya 
which alleviates Pitta kapha. Caraka acharya mentioned it 
as best Kustahara dravya in Agraprakarana. It has also the 
properties of Switraghna. Kandugna, Kustagna, Krimihara. 
The decoction has the important ingredients like catecnin 
(flavanoid), catechu tannic acid and tennis. There by 
Khadira helps for better absorption. 
Bakuchi is having Madhura, Tikta, Katu, Sitavirya, 
Tridoshahara. Twachya, Kushthahna, Rasayana, Switragna, 
Krimigna[11]. As per modern aspect Bakuchi has the effect 
on Ronget‟s cell and melanoblast cells of skin. It stimulates 
melanocytes for the production of melanin. Bakuchi 
contain several types of Furocaumarins precursors such as 
psoralin. Furocaumarins are primary photodynamic 
agents. They absorb long wave ultraviolet radiations after 
exposure to sun light and Become photoactive[12,13]. 
Dhatryadi yoga having Amalaki, Khadira and 
Bakuchi as Kushthahna, Switraghna property. Along with 
this Amalaki and Khadira have Vyadhipratyanik effect and 
Bakuchi being the main drug of choice in Switra added 
with Amalaki which imparts the dye and Khadira helps in 
better absorption. Apart from above properties all the 
three drugs have Rasayana effect which can maintain the 
healthy status of Dhatu. 
External application effect 
Aparajitha katu, Tikta, Kashaya rasa,  Laghu, 
Ruksha guna, Sita virya, Katu vipaka, Tridoshahara, 
Vishagna, Kusthagna, kandugna. As Switra is a Pitta 
pradhana tridoshaja Vyadi, there is involvement of 
Bhrajaka Pitta which is said to be located in external skin 
(Bahya Twak) and responsible for color of different parts 
of the body.  
It is responsible for digestion, metabolism and 
absorption of the substances which are applied over the 
skin. In general, it could be assumed that Bhrajaka Pitta is 
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a substance which is responsible or related with 
Pigmentary system of the body. While describing about 
location of Pitta, Sushruta used the term Bhrajaka Agni in 
place of Bhrajaka Pitta and said that it is responsible for 
metabolism or utilization of the substances, used as 
external application. Acharya Sushruta said that Abhyanga, 
Parisheka, Lepana & Avagahana like external applications 
are digested by the Bhrajaka Pitta and produces its effect 
over the skin. 
Combined effect of both internal and external 
medicines 
The drugs that are administered internally 
(Dhatryadi kwatha) are digested by the Agni and with the 
help of Vyana vayu are carried through the Tiryak 
Dhamanies towards Twak (Switra) to produce their action 
internally and the external application (Aparajitha lepa) 
are digested by the Bhrajaka Pitta to produce their action 
over Twak (Switra) externally. Hence both internal as well 
as external therapies have worked combinedly. [14] 
Limitations 
1. The first limitation is relatively small sample so 
further study is necessary to evaluate the effect of the 
management in a large sample with long duration 
2. The study has been done as a whole on Switra but it 
would better to do further study with the same 
combinations on various types of Switra. 
3. Here the study included both internal and external 
application, so another study is needed to compare the 
efficacy of both the Yogas alone. 
CONCLUSION 
Vitiligo is a common puzzling disorder of great 
socio-medical importance characterized by hypo 
pigmented and/or depigmented milky white or ivory 
white macules on the skin, resulting from the loss of 
cutaneous melanocytes. It affects approximately 1-4% of 
world population in both sexes equally. 
As per the general principal of treatment for this 
disease, repeated application of Shodana karma, shaman 
karma as well is beneficial. But Sodhana being difficult to 
perform in children. So shaman therapy is under taken. 
Many Ayurvedic medicines both internal and external are 
known to regenerate melanocytes, among one is Dhatryadi 
Kwatha and Aparajitha Lepa which were said in our 
classics. The present study is to prove the efficacy of the 
above mentioned Yoga. The given treatment is efficacious, 
repigmentation was seen in overall of 42.49%, 
Considerable improvement in Romavivarnatha (69.84%) is 
observed, Kandu and Twakrukshata has a result of 74.07% 
and 55.22% respectively. Daha symptom which was seen 
in two persons has been relieved completely. Out of 30 
patients 20% had no reappearance of lesions during the 
study period.  
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